None of the estimates for this medical drugs stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Avanir Pharmaceuticals currently carries a Zacks Rank #2 (Buy) while its Earnings ESP is positive.
Other well-placed stocks in the same industry include IGI, Laboratories, Inc. (IG), Lannett Company, Inc. (LCI) and Sucampo Pharmaceuticals, Inc. (SCMP). All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment